<p>許多 <strong>Prestige Consumer Healthcare Inc.</strong> (NYSE:PBH) 的內部人士在過去一年裏拋售了他們的股票，這可能引起公司股東的關注。瞭解內部人士是否在買入通常在評估內部交易時更為有用，因為內部人士的賣出可能有多種解釋。然而，如果許多內部人士都在賣出，股東應該進一步調查。</p>
<p>儘管我們認為股東不應僅僅跟隨內部交易，但邏輯上你應該關注內部人士是否在買入或賣出股票。</p>
<p>特朗普承諾要 “釋放” 美國的石油和天然氣，這 15 只美國股票的發展有望受益。</p>
<h2>Prestige Consumer Healthcare 最近一年的內部交易</h2>
<p>在過去的十二個月中，內部人士最大的單筆出售是質量與監管事務高級副總裁 Mary Fritz 以每股 81.99 美元的價格出售了價值 81 萬美元的股票。我們通常不喜歡看到內部人士的賣出，但賣出價格越低，我們越感到擔憂。值得安慰的是，這筆交易的價格遠高於當前的股價 65.05 美元。因此，這可能對當前水平的內部信心沒有太多啓示。</p>
<p>在過去一年中，Prestige Consumer Healthcare 的內部人士沒有購買任何公司股票。你可以在下面的圖表中看到過去一年內部交易（按公司和個人劃分）的情況。點擊下面的圖表，你可以查看每筆內部交易的具體細節！</p>
<p>查看我們對 Prestige Consumer Healthcare 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/10969688-insider-trading-volume-1-dark-2/1757246984388?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/10969688-insider-trading-volume-1-dark-2/1757246984388"/></p>
<p>NYSE:PBH 內部交易量 2025 年 9 月 7 日</p>
<p>如果你和我一樣，那麼你一定不想錯過這份 <strong>免費的</strong> 小型股名單，這些股票不僅被內部人士購買，而且估值也很有吸引力。</p>
<h2>內部持股</h2>
<p>我喜歡查看內部人士在公司中擁有多少股份，以幫助我判斷他們與內部人士的利益一致性。通常，內部持股越高，內部人士越有可能受到激勵以長期發展公司。內部人士擁有 1.1% 的 Prestige Consumer Healthcare 股票，價值約 3700 萬美元。這個內部持股水平不錯，但略低於特別突出。它確實表明了一定程度的利益一致性。</p>
<h2>那麼 Prestige Consumer Healthcare 的內部交易表明了什麼？</h2>
<p>最近沒有 Prestige Consumer Healthcare 的內部交易，這一點確實不會讓我們感到困擾。我們對 Prestige Consumer Healthcare 內部人士的交易並沒有太多鼓勵。適度的內部持股水平至少讓人感到一些安慰。雖然瞭解內部人士的持股和交易情況是好的，但在做出任何投資決策之前，我們也確保考慮股票面臨的風險。在投資風險方面，我們已經識別出 <strong>1 個警示信號</strong>，瞭解這一點應該是你投資過程的一部分。</p>
<p>如果你更願意查看另一家公司——一家可能財務狀況更優越的公司——那麼不要錯過這份 <strong>免費的</strong> 有趣公司名單，這些公司具有高股本回報率和低債務。</p>
<p><em>在本文中，內部人士是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置，但不包括衍生交易或間接利益。</em></p>

普雷斯蒂奇

<p>Prestige Consumer Healthcare Inc.（紐約證券交易所代碼：PBH）的內部人士在過去一年中出售了大量股票，這引發了股東的擔憂。最大的一筆出售是由高級副總裁 Mary Fritz 進行的，她以每股 81.99 美元的價格出售了價值 81 萬美元的股票，遠高於當前的 65.05 美元價格。最近沒有內部人士購買股票，內部持股比例為 1.1%。雖然近期缺乏交易並不令人擔憂，但這表明股東在投資前需要考慮潛在風險</p>

<p>Many <strong>Prestige Consumer Healthcare Inc.</strong> (NYSE:PBH) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. Knowing whether insiders are buying is usually more helpful when evaluating insider transactions, as insider selling can have various explanations. However, if numerous insiders are selling, shareholders should investigate more.</p>
<div class="lb-trans"><p>許多 <strong>Prestige Consumer Healthcare Inc.</strong> (NYSE:PBH) 的內部人士在過去一年裏拋售了他們的股票，這可能引起公司股東的關注。瞭解內部人士是否在買入通常在評估內部交易時更為有用，因為內部人士的賣出可能有多種解釋。然而，如果許多內部人士都在賣出，股東應該進一步調查。</p>
</div><p>Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.</p>
<div class="lb-trans"><p>儘管我們認為股東不應僅僅跟隨內部交易，但邏輯上你應該關注內部人士是否在買入或賣出股票。</p>
</div><p>Trump has pledged to &#34;unleash&#34; American oil and gas and these 15 US stocks have developments that are poised to benefit.</p>
<div class="lb-trans"><p>特朗普承諾要 “釋放” 美國的石油和天然氣，這 15 只美國股票的發展有望受益。</p>
</div><h2>Prestige Consumer Healthcare Insider Transactions Over The Last Year</h2>
<div class="lb-trans"><h2>Prestige Consumer Healthcare 最近一年的內部交易</h2>
</div><p>In the last twelve months, the biggest single sale by an insider was when the Senior Vice President of Quality &amp; Regulatory Affairs, Mary Fritz, sold US$810k worth of shares at a price of US$81.99 per share. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. It's of some comfort that this sale was conducted at a price well above the current share price, which is US$65.05. So it may not shed much light on insider confidence at current levels.</p>
<div class="lb-trans"><p>在過去的十二個月中，內部人士最大的單筆出售是質量與監管事務高級副總裁 Mary Fritz 以每股 81.99 美元的價格出售了價值 81 萬美元的股票。我們通常不喜歡看到內部人士的賣出，但賣出價格越低，我們越感到擔憂。值得安慰的是，這筆交易的價格遠高於當前的股價 65.05 美元。因此，這可能對當前水平的內部信心沒有太多啓示。</p>
</div><p>In the last year Prestige Consumer Healthcare insiders didn't buy any company stock. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!</p>
<div class="lb-trans"><p>在過去一年中，Prestige Consumer Healthcare 的內部人士沒有購買任何公司股票。你可以在下面的圖表中看到過去一年內部交易（按公司和個人劃分）的情況。點擊下面的圖表，你可以查看每筆內部交易的具體細節！</p>
</div><p>See our latest analysis for Prestige Consumer Healthcare</p>
<div class="lb-trans"><p>查看我們對 Prestige Consumer Healthcare 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/10969688-insider-trading-volume-1-dark-2/1757246984388" alt="" original-src="https://images.simplywall.st/asset/chart/10969688-insider-trading-volume-1-dark-2/1757246984388"/></p>
<p>NYSE:PBH Insider Trading Volume September 7th 2025</p>
<div class="lb-trans"><p>NYSE:PBH 內部交易量 2025 年 9 月 7 日</p>
</div><p>If you are like me, then you will <strong>not</strong> want to miss this <strong>free</strong> list of small cap stocks that are not only being bought by insiders but also have attractive valuations.</p>
<div class="lb-trans"><p>如果你和我一樣，那麼你一定不想錯過這份 <strong>免費的</strong> 小型股名單，這些股票不僅被內部人士購買，而且估值也很有吸引力。</p>
</div><h2>Insider Ownership</h2>
<div class="lb-trans"><h2>內部持股</h2>
</div><p>I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Insiders own 1.1% of Prestige Consumer Healthcare shares, worth about US$37m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.</p>
<div class="lb-trans"><p>我喜歡查看內部人士在公司中擁有多少股份，以幫助我判斷他們與內部人士的利益一致性。通常，內部持股越高，內部人士越有可能受到激勵以長期發展公司。內部人士擁有 1.1% 的 Prestige Consumer Healthcare 股票，價值約 3700 萬美元。這個內部持股水平不錯，但略低於特別突出。它確實表明了一定程度的利益一致性。</p>
</div><h2>So What Do The Prestige Consumer Healthcare Insider Transactions Indicate?</h2>
<div class="lb-trans"><h2>那麼 Prestige Consumer Healthcare 的內部交易表明了什麼？</h2>
</div><p>The fact that there have been no Prestige Consumer Healthcare insider transactions recently certainly doesn't bother us. We don't take much encouragement from the transactions by Prestige Consumer Healthcare insiders. The modest level of insider ownership is, at least, some comfort. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. In terms of investment risks, <strong>we've identified 1 warning sign</strong> with Prestige Consumer Healthcare and understanding this should be part of your investment process.</p>
<div class="lb-trans"><p>最近沒有 Prestige Consumer Healthcare 的內部交易，這一點確實不會讓我們感到困擾。我們對 Prestige Consumer Healthcare 內部人士的交易並沒有太多鼓勵。適度的內部持股水平至少讓人感到一些安慰。雖然瞭解內部人士的持股和交易情況是好的，但在做出任何投資決策之前，我們也確保考慮股票面臨的風險。在投資風險方面，我們已經識別出 <strong>1 個警示信號</strong>，瞭解這一點應該是你投資過程的一部分。</p>
</div><p>If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this <strong>free</strong> list of interesting companies, that have HIGH return on equity and low debt.</p>
<div class="lb-trans"><p>如果你更願意查看另一家公司——一家可能財務狀況更優越的公司——那麼不要錯過這份 <strong>免費的</strong> 有趣公司名單，這些公司具有高股本回報率和低債務。</p>
</div><p><em>For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.</em></p>
<div class="lb-trans"><p><em>在本文中，內部人士是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置，但不包括衍生交易或間接利益。</em></p>
</div>

普雷斯蒂奇消費者醫療保健公司的內部人士正在出售股票，這可能是一個看跌信號